Cargando…
Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience
BACKGROUND: Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that offer therapies with reduced side effects but reduced efficacy. We analysed the ou...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408447/ https://www.ncbi.nlm.nih.gov/pubmed/28454549 http://dx.doi.org/10.1186/s13014-017-0809-9 |